16.10
Schlusskurs vom Vortag:
$16.51
Offen:
$16.51
24-Stunden-Volumen:
515.32K
Relative Volume:
0.40
Marktkapitalisierung:
$957.12M
Einnahmen:
$260.21M
Nettoeinkommen (Verlust:
$-12.78M
KGV:
-70.40
EPS:
-0.2287
Netto-Cashflow:
$12.42M
1W Leistung:
-2.92%
1M Leistung:
+12.45%
6M Leistung:
-11.46%
1J Leistung:
+0.00%
Omada Health Inc Stock (OMDA) Company Profile
Firmenname
Omada Health Inc
Sektor
Branche
Telefon
888-987-8337
Adresse
611 GATEWAY BLVD., SOUTH SAN FRANCISCO
Compare OMDA vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
OMDA
Omada Health Inc
|
16.10 | 981.49M | 260.21M | -12.78M | 12.42M | -0.2287 |
|
VEEV
Veeva Systems Inc
|
158.56 | 26.14B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
60.32 | 11.34B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
46.64 | 8.29B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
87.33 | 7.39B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
HNGE
Hinge Health Inc
|
52.98 | 4.28B | 646.34M | -512.40M | 202.76M | -6.6871 |
Omada Health Inc Stock (OMDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Eingeleitet | Citizens | Mkt Outperform |
| 2026-01-09 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-09-05 | Eingeleitet | Robert W. Baird | Neutral |
| 2025-07-01 | Eingeleitet | Barclays | Overweight |
| 2025-07-01 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-01 | Eingeleitet | Evercore ISI | Outperform |
| 2025-07-01 | Eingeleitet | Goldman | Buy |
| 2025-07-01 | Eingeleitet | JP Morgan | Overweight |
| 2025-07-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-07-01 | Eingeleitet | Needham | Buy |
Alle ansehen
Omada Health Inc Aktie (OMDA) Neueste Nachrichten
OMDA Should I Buy - Intellectia AI
Oceaneering Stock Is Up 105% in a Year, and One Fund Just Disclosed a $7 Million Bet on More Growth - The Motley Fool
Omada Health’s people chief on HR strategy spring cleaning - HR Brew
Omada Health: A Great Company Without Pricing Power (NASDAQ:OMDA) - Seeking Alpha
Morgan Stanley Maintains Omada Health(OMDA.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Compared to estimates, Omada Health, Inc. (OMDA) Q1 earnings: A look at key metrics - MSN
Andreessen Horowitz affiliates report OMDA stakes (OMDA) — March 31, 2026 - Stock Titan
Divisadero Group discloses 9.9% stake in Omada Health (OMDA) - Stock Titan
Omada Health (OMDA) price target decreased by 16.75% to 22.54 - MSN
How this Eli Lilly-tied IPO stock fared in its first quarter - MSN
Number of shareholders of Omada Health, Inc. – NASDAQ:OMDA - TradingView
Scaling Risks Cloud Omada Health’s Growth Prospects Amid Limited Operating History - TipRanks
The Private Shares Fund's Omada Health Inc(OMDA) Holding History - GuruFocus
BMO Capital Sticks to Its Buy Rating for Omada Health, Inc. (OMDA) - The Globe and Mail
Omada Health Earnings Call Signals Profitable Scale - TipRanks
CCORF Maintains Omada Health(OMDA.US) With Buy Rating, Raises Target Price to $24 - Moomoo
Omada Health price target raised to $18 from $17 at Wells Fargo - TipRanks
42% revenue surge as Omada Health (NASDAQ: OMDA) narrows Q1 2026 loss - Stock Titan
Omada Health (OMDA) Q1 2026 Earnings Transcript - AOL.com
Omada Health reports 42% revenue boost, GLP-1 partnership - TechTarget
Omada Health Q1 2026 slides: 42% revenue growth, positive EBITDA By Investing.com - Investing.com Australia
Omada Health Q1 Earnings Call Highlights - Barchart.com
Citizens raises Omada Health stock price target on growth outlook By Investing.com - Investing.com South Africa
Citizens raises Omada Health stock price target on growth outlook - Investing.com UK
Omada Health Q1 2026 slides: 42% revenue growth, positive EBITDA - Investing.com
Omada Health Q1 2026 Earnings Call Transcript - MarketBeat
Earnings call transcript: Omada Health Q1 2026 sees EPS beat, stock rises - Investing.com Nigeria
Omada outlines 2026 revenue of $322M-$330M as adjusted EBITDA guidance rises to $14M-$20M - MSN
Compared to Estimates, Omada Health, Inc. (OMDA) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Omada Health joins Eli Lilly employer weight loss program - Investing.com
Omada Health joins Eli Lilly employer weight loss program By Investing.com - Investing.com South Africa
Omada Health (NASDAQ:OMDA) Soars on Q1 Beat, Raised Guidance and Key Partnerships - ChartMill
OMADA HEALTH ($OMDA) Releases Q1 2026 Earnings, Stock Rises - Quiver Quantitative
Earnings Flash (OMDA) Omada Health, Inc. Reports Q1 Revenue $78.0M, vs. FactSet Est of $74.1M - marketscreener.com
44% of surveyed GLP-1 patients pay over $250 a month as Omada adds Lilly channel - Stock Titan
Omada Health Reports First Quarter 2026 Results - The Manila Times
Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support - Yahoo Finance
One million members: Omada now works with all 3 top drug-benefit managers - Stock Titan
Omada Health 1Q Loss/Shr 5c >OMDA - Moomoo
Omada Health (NASDAQ: OMDA) posts 42% Q1 revenue jump, raises 2026 outlook - Stock Titan
Omada Health, Inc. Provides Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
FMR LLC discloses 3.29M-share stake in Omada Health (NASDAQ: OMDA) - Stock Titan
CCORF Maintains Omada Health(OMDA.US) With Buy Rating, Maintains Target Price $22 - Moomoo
Analyst Reiterates Buy on Omada Health, Maintains $22 Price Target on Robust GLP-1-Driven Demand and Strategic Partnerships - TipRanks
77,451 Shares in Omada Health, Inc. $OMDA Acquired by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Earnings Preview: Omada Health to Report Financial Results Post-market on May 07 - Moomoo
Finanzdaten der Omada Health Inc-Aktie (OMDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):